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Abstract
Background: Specific delivery to synapses of a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors with
long-tailed subunits is believed to be a key event in many forms of activity-dependent changes in synaptic strength. GluA1,
the best characterized long-tailed AMPA receptor subunit, contains a C-terminal class I PDZ binding motif, which mediates
its interaction with scaffold and trafficking proteins, including synapse-associated protein 97 (SAP97). In GluA4, another
long-tailed subunit implicated in synaptic plasticity, the PDZ motif is blocked by a single proline residue. This feature is
highly conserved in vertebrates, whereas the closest invertebrate homologs of GluA4 have a canonical class I PDZ binding
motif. In this work, we have examined the role of GluA4 in PDZ interactions.
Methodology/Principal Findings: Deletion of the carboxy-terminal proline residue of recombinant GluA4 conferred avid
binding to SAP97 in cultured cells as shown by coimmunoprecipitation, whereas wild-type GluA4 did not associate with
SAP97. Native GluA4 and SAP97 coimmunoprecipitated from mouse brain independently of the GluA1 subunit, supporting
the possibility of in vivo PDZ interaction. To obtain evidence for or against the exposure of the PDZ motif by
carboxyterminal processing of native GluA4 receptors, we generated an antibody reagent specific for proline-deleted GluA4
C-terminus. Immunoprecipitation and mass spectrometric analyses indicated that the carboxyl-terminus of native GluA4
AMPA receptors is intact and that the postulated single-residue cleavage does not occur to any significant extent.
Conclusion/Significance: We conclude that native GluA4 receptors are not capable of canonical PDZ interactions and that
their association with SAP97 is likely to be indirect.
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Introduction
AMPA receptors mediate the majority of mammalian fast
excitatory neurotransmission and play important roles in synaptic
plasticity. AMPA receptors are tetramers composed of various
combinations of four homologous subunits GluA1 to 4 (alterna-
tively GluR-A to -D, or GluR1-4). The number and subunit
composition are important determinants of synaptic strength.
Subunit-specific AMPA receptor trafficking is largely governed by
the cytoplasmic C-terminal tails (CTDs) (reviewed in [1,2]); with
the specific activity-dependent insertion of the long-tailed (70–80
residues) subunits GluA1, GluA2L (minor isoform) and GluA4
occuring in various forms of synaptic plasticity, leading to
enhanced AMPA receptor responses [3–7].
Due to its central role in hippocampal CA3-to-CA1 pyramidal
cell synapses [8,9] GluA1 trafficking has received more attention
than either GluA4 and GluA2L. The C-terminus of GluA1 has a
canonical class I PDZ motif and mutations at this motif prevent
activity-dependent transport of GluA1 to synapses in hippocampal
slice preparations and in cultured neurons [4,7,10]. Interestingly,
the total elimination of the PDZ motif, by a seven-residue deletion,
leaves GluA1-dependent synaptic plasticity intact [11,12], sugges-
tive of a complex interplay between multiple C-terminal PDZ- and
non-PDZ interactions. Reported PDZ interaction partners for
GluA1 include SAP97 [13–16], mLin-10 [17], syntenin [18] and
Shank3 [19]. Notably, overexpression of SAP97 drives GluA1 to
synapses and occludes long-term potentiation [16,20], whereas its
RNAi knockdown reduces surface levels of GluA1 in neurons [20].
Moreover, SAP97 is present in the postsynaptic membrane and
has a peripheral localization in the postsynaptic density, consistent
with a role in the insertion or stabilization of AMPA receptors
[21–23].
While less studied than GluA1, both GluA4 and GluA2L are
also implicated in synaptic plasticity [5,6,24]. Direct protein
interactions of GluA4 CTD include 4.1N [25], PKCc [26], a-
actinin-1 and IQGAP1 [27], but none of these involve the extreme
carboxy terminus. The CTDs of GluA4 and GluA2L and share
several sequence characteristics with GluA1, including the residues
corresponding to the PDZ motif. However, one extra residue,
proline in GluA4, and serine in GluA2L, blocks the PDZ motif.
Given the existence of cytosolic carboxypeptidases in the nervous
system [28], the possibility thus arises that limited proteolytic
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cleavage of GluA4 C-terminus could expose the PDZ motif in vivo
to faciliate interactions with PDZ domain-containing trafficking
proteins. An analogous mechanism involving enzymatic removal
of a single C-terminal residue operates in the detyrosination of a-
tubulin in the brain and peripheral tissues [28,29]. AMPA
receptor cytoplasmic tails are subject to proteolytic cleavage in
hippocampal slices following stimulation [30], and both calpain
[31–33] and caspase-8 [34] mediated cleavage of GluA1 C-
terminal tail have been suggested to play a role in excitotoxic
processes following raised intracellular Ca2+ levels.
In the present study, we analyzed the interaction of GluA4 with
SAP97 in cultured cells and in vivo, specifically addressing the
hypothesis that the carboxy-terminus of native GluA4 is subject to
proteolytic processing to reveal the PDZ motif. We show that
native GluA4 is associated with SAP97, independently of its
coassembly with the GluA1 subunit. However, immunochemical
and mass spectrometric analyses indicate that the hypothesized
cleavage of GluA4 C-terminus by endogenous enzymatic activity
in neurons does not occur to any detectable extent, and therefore,
the association with SAP97 is likely to be indirect and/or mediated
by non-PDZ mechanisms.
Results and Discussion
The sequence similarities in the CTDs of the long-tailed AMPA
receptor subunits are illustrated in Figure 1. In rat GluA4 and
GluA2L, the residues corresponding to the class I PDZ motif in
GluA1 are conserved, but followed by a single ‘‘blocking’’ residue
(Figure 1A). The extreme carboxyterminal tetrapeptide sequence,
including the cryptic PDZ motif and the blocking residue, are
absolutely conserved in GluA4 orthologs representing widely
disparate vertebrate lineages (Figure 1B). This is consistent with
important function(s), most likely, C-terminus -dependent protein
interactions, but none such are known. The carboxyl-terminal tail
of GluA2L shows a similar high degree of sequence conservation
(Figure S1). Interestingly, the invertebrate homologs showing the
closest similarity to GluA4 C-terminus have a genuine class I PDZ
motif with no blocking residue (Figure 1C). Importantly, the
sequence pattern KARLS/T, a distinguishing feature of GluA2L
and A4 subunits as opposed to GluA1, is present in the
invertebrate sequences, arguing for a closer kinship to GluA4/
2L. These findings raise the possibility that the blocking residue in
vertebrate ‘‘non-GluA1’’ long-tailed AMPA receptor subunits may
have evolved to faciliate its regulated exposure to PDZ
interactions.
A previous study using bacterially expressed protein domains
demonstrated that removal of the extreme C-terminal proline
resulted in avid binding of GluA4 CTD to PDZ domains of SAP97
under in vitro conditions with purified proteins [13]. To investigate
the potential functionality of GluA4 cryptic PDZ motif in living
mammalian cells, full-length wild-type (wt) and mutated flag-
tagged GluA4 were expressed in transfected HEK293 cells
together with myc-tagged SAP97. Coimmunoprecipitation from
detergent extracts of cell homogenates showed no association
between wt GluA4 and SAP97, whereas the GluA4 mutant lacking
proline-902 (GluA4DP) immunoprecipitated as a complex with
SAP97 (Figure 2A). Next, we wished to determine if GluA4DP also
associated with the endogenously expressed SAP97 in HEK293
cells, and whether the interaction shows features typical of class I
PDZ interactions. Thus, HEK293 cells were transfected for
expression of N-terminally GFP-tagged GluA4 constructs, fol-
lowed by immunoprecipitation with anti-SAP97 sera. Consistent
with the above results GFP-tagged GluA4DP, but not the wild-
type receptor, co-precipitated with SAP97. Disruption of the
exposed PDZ interaction motif, either by further deletion of the
carboxyl-terminal Leu-901 (GluA4DLP) or by mutation of Ser-899
and Leu-901 to alanine [GluA4(SLRAA)DP], abolished the
interaction (Figure 2B). This is in agreement with the requirement
for a large aliphatic side chain at the carboxy-terminal position for
class I PDZ interactions.
Figure 1. Sequence characteristics of long-tailed AMPA receptor subunits. (A) Alignment of the unique carboxyterminal extensions of rat
long-tailed GluA1, GluA2L and GluA4 subunits. The accession codes (SwissProt/TrEMBL) for the sequences are: GluA1, P19490; GluA4, P19493; GluA2L,
P23819-3. (B) Conservation of GluA4 C-terminal sequence in vertebrate evolution. The indicated GluA4 orthologs represent diverse vertebrate
lineages: mammals (Rattus norvegicus, rat, P19490), birds (Gallus gallus, chicken, Q90858), bony fishes (Danio rerio, zebra fish, Q71E58) and amphibians
(Xenopus tropicalis, western clawed frog; the sequence represents a virtual translation of Genbank EST CX366243). (C) Alignment of mammalian GluA4
carboxyterminal sequence with its closest invertebrate homologs: Mammal (rat); Beetle, (Tribolium castaneum, Red flour beetle, XP 968786); Louse,
(Pediculus humanus corporis, human body louse, XP 002430327); Snail (Lymnaea stagnalis, great pond snail, CAA42683); Aplysia (Aplysia californica,
California sea har, ABB03888). In all alignments, the residues conforming to the class I PDZ motif (-Thr/Ser-X-W; W denoting an amino acid residue with
large aliphatic side chain, X standing for any amino acid) are highlighted in yellow. Asterisks indicate identical residues, whereas strong and weak
similarities (according to Gonnet Pam250 matrix [49]) are indicated by colons and dots, respectively.
doi:10.1371/journal.pone.0008715.g001
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Having confirmed the potential capability of proline-deleted
GluA4 for PDZ interactions with SAP97, we next wished to
determine whether native GluA4 receptors associate with SAP97
or with related PDZ proteins. Extracts from whole brain
homogenates of adult mice were immunoprecipitated with anti-
SAP97 or anti-PDZ, a broadly specific antiserum recognizing all
four postsynaptic density-95 (PSD-95) family membrane-associat-
ed guanylate kinase homologs (Maguks) (Figure S2). The
corresponding preimmune sera served as specificity controls.
Immunoblot analysis, performed with antibody specific for GluA4
N-terminal domain (anti-Dx [25]) showed the presence of GluA4
in both anti-SAP97 and anti-PDZ immunoprecipitates (Figure 3A).
GluA1, employed as a positive control, coimmunoprecipitated
with SAP97 as expected. Substantial coimmunoprecipitation of
GluA4 and GluA1 was also noticed, consistent with the existence of
GluA1/4 heteromeric receptors (Figure 3A). In principle, coassembly
with GluA1 subunit would lead to physical association of GluA4
subunits with SAP97 without any direct interaction [14]. To determine
if this is the case, immunoprecipitations were also performed from
mutant mice lacking GluA1 expression (GluA12/2; [9]). Immunore-
active GluA4 was prominently present in anti-SAP97 and anti-PDZ
immunoprecipitates prepared from brains of GluA12/2 mice,
indicating that GluA4 can associate with SAP97 independently of
GluA1 (Figure 3B). Conversely, SAP97 was present in the GluA4
immunoprecipitates prepared from both wild-type and GluA1
knockout mice (Figure 3A,B).
If the in vivo association of GluA4 with SAP97 was due to the
exposure of its cryptic PDZ motif by a cellular carboxypeptidase(s),
GluA4 preparations isolated from native tissue should contain
modified C-termini with potentially identifiable protein chemical
or immunochemical signatures. To address this possibility, we
utilized MALDI-TOF mass spectrometry to analyze tryptic digests
of the ,100-kDa receptor band obtained from GluA4 immuno-
precipitates prepared from rat brain homogenates. Two different
antibodies were employed, anti-BDL, a rabbit polyclonal antibody
recognizing the long CTDs of both GluA4 and GluA2 subunits
[35] and Fab7, a monoclonal antibody specific for a conforma-
tional epitope present in the N-terminal domains of GluA4 and
GluA2 subunits [36]. However, mass spectrometric analysis failed
to identify any C-termini of either wild-type or modified versions
of GluA4 in spite of an abundance of peptides corresponding to
other regions of the receptor polypeptides (Table 1 and Table S1).
Due to the failure of direct mass spectrometric identification of
GluA4 C-terminus, we decided upon an immunochemical
approach. The polyclonal anti-BDL antiserum was originally
generated by using GluA4 CTD lacking the C-terminal proline as
Figure 2. Deletion of proline-902 exposes a functional PDZ
motif in GluA4 and confers binding to SAP97. (A) Expression of
wild-type or mutant GluA4, with or without co-expressed myc-tagged
SAP97 in HEK293 cells. Upper panels show expression of all proteins;
lower panels show co-immunoprecipitation of GluA4DP, but not full-
length GluA4 with SAP97. Immunoblotting antibodies are indicated on
right. (B) Transiently expressed GluA4DP can co- immunoprecipitate
with endogenous SAP97 from HEK293 cells. Upper panel shows similar
expression levels of transfected GFP-tagged constructs. Lower panel
show immunoprecipitation with anti-SAP97 specific antibody. Both
blots were probed with anti-GFP IgG. The extreme carboxyterminal
sequences of the expressed proteins are shown below.
doi:10.1371/journal.pone.0008715.g002
Figure 3. Native GluA4 AMPA receptors interact with SAP97.
Whole brain detergent extracts prepared from (A) wild-type (WT,
GluA1+/+) and (B) GluA1 knockout mice (GluA12/2) were subjected to
immunoprecipitation. Immunoprecipitating antibodies are indicated on
top; whereas antibodies used for detection of the immunocomplexes
are shown on the left.
doi:10.1371/journal.pone.0008715.g003
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the antigen, and therefore it may contain also antibodies binding
specifically to the extreme, processed C-terminus. However, in
immunoblots, anti-BDL serum recognizes GluA2L, GluA4 and
GluA4DP in an equally robust manner (Figure 4A, middle panel),
suggesting that antibodies specific for GluA4DP are a small
minority. To enrich GluA4DP-specific antibodies potentially
present in anti-BDL preparations, the antiserum was repeatedly
adsorbed to purified glutathione S-transferase (GST) fusion
protein of wild-type GluA4 CTD, thereby depleting antibodies
which bind to epitopes shared by GluA4DP CTD and wild-type
CTD. The specificity of the final immunoreagent was determined
by immunoblotting against the full range of AMPA receptor
subunit CTDs. As expected, the depleted antiserum, ‘anti-DP’, did
not any more recognize the wild-type GluA2L or GluA4 subunits
(or any other wild-type subunit), but reacted strongly with
GluA4DP (Figure 4A, bottom panel). Similar specificity was
observed in the immunofluorescence analysis of GluA4 and
GluA4DP receptors expressed in transiently transfected HEK293
cells: the original anti-BDL stained both GluA4 and GluA4DP
transfectants, whilst anti-DP stained only the proline-deleted
receptors (Figure S3A). In peptide competition experiments,
binding of anti-DP to GluA4DP was abolished by a 13mer peptide
corresponding to GluA4DP carboxyl-terminus, but not by a
corresponding 14mer ‘‘wild-type’’ peptide (Figure S3B).
Having established an acceptable specificity for anti-DP
antibody preparation, we used it in direct immunoblots of rat
brain extracts. Anti-DP recognized a ,100-kDa band, consistent
with the size of GluA4 and other AMPA receptor subunits
(Figure 4B). Detection of this band was fully blocked by the 13mer
peptide, whereas the wild-type 14mer peptide had a much weaker
inhibitory effect (Figure 4B, upper panel). Commerical GluA4-
specific antibody (anti-GluR4) also recognized a band of
approximately 100 kD, and in this case, the detection was weakly
inhibited by the 13mer peptide and eliminated completely by the
14mer peptide (Figure 4B, lower panel). These findings are
consistent with the potential existence in the brain of a
subpopulation of GluA4 receptors with processed C-termini.
However, direct tissue blots contain highly complex protein
mixtures with the caveat that the 100-kb band may be caused by
some rare crossreacting species. Therefore, we performed
immunoblot analyses from preparations enriched for GluA4-
containing AMPA receptors by using anti-GluR4 or Fab7 [36].
Both immunoprecipitaties reacted strongly with anti-GluR4,
consistent with enrichment of native GluA4 receptors, but no
anti-DP immunoreactivity was observed (Figure 4C). As Fab 7
recognizes an epitope in the N-terminal domain of GluA4, it
should not be affected by possible C-terminal processing or protein
interactions which may interfere with the binding of antibodies to
carboxylterminal epitopes (like anti-GluR4). Therefore, the results
suggest that native GluA4 receptors do not undergo the postulated
carboxylterminal single-residue cleavage.
Finally, mass spectrometric peptide fingerprinting analysis of
anti-DP immunoprecipitate was performed to substantiate the
above results and to determine the identity of the 100-kDa anti-
DP immunoreactive band. In contrast to the similar analysis of
Table 1. MALDI-TOF mass spectrometric peptide fingerprint
analysis of the 100-kDa protein band present in the
immunoprecipitates.
Immunoprecipitating
antibody Primary match
Intensity
coverage
Anti-BDLONG IgG AMPA receptor subunits 71.4%
Fab 7 AMPA receptor subunits 77.9%
Anti-DDP IgG Dynamin 1 79.2%
doi:10.1371/journal.pone.0008715.t001
Figure 4. Analysis of AMPA receptors with an antibody specific
for the exposed PDZ motif in GluA4DP. (A) HEK293 cells
expressing flag-tagged AMPA receptor subunits with all potential
wild-type CTDs and the mutant GluA4DP (indicated above) were
immunoblotted with the antibodies indicated to the left. Short-tailed
isoforms of GluA2 and GluA4 are indicated by SH. The initial antiserum,
anti-BDL detects both A2 and A4 long tails isoforms and GluA4DP. After
the depletion procedure and purification, the anti-DP IgG only
recognises GluA4DP (lower panel). (B) Anti-DP IgG labels a single
100 kD band in rat cerebellar tissue; this is specifically blocked by
preincubation with 13mer peptide (upper panels). Similarly anti-GluR4
IgG also labels a 100 kDa band. This labelling is blocked by pre-
incubation with 14 mer peptide (lower panels). (C) Immunoprecipitation
from rat cerebellar extract using independent AMPA receptor
antibodies fails to bring down anti-DDP immunoreactivity (upper
panel). An alternative antibody shows GluA4 levels were highly
enriched in the immunoprecipitates (lower panel).
doi:10.1371/journal.pone.0008715.g004
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the anti-BDL immunoprecipitated 100-kDa species (Tables 1
and S1), no AMPA receptor -derived peptides were identified.
Instead, the most prominent peptides represented dynamin 1,
which has a predicted size of 97.2–97.4 kDa, depending on the
splice form (Tables 1 and S2). Moreover, a commercial
dynamin antibody strongly labelled anti-DP immunoprecipi-
tates (but not AMPA receptor immunoprecipitates) and
recognised a 100 kDa band in rat cerebellar tissue (Figure
S4A). Strikingly, the extreme C-terminal peptide of dynamin 1,
which was also identified in the fingerprint, shares the C-
terminal sequence, DL (Asp-Leu), with GluA4DP (Table S2).
This finding suggests that the carboxyterminal DL dipeptide is
the major epitope recognized by the DP-antibody. Consistent
with this, anti-DP avidly binds to a fusion protein containing the
carboxyterminal peptide of dynamin 1 (Figure S4B). In
addition, deletion of the carboxyterminal serine from GluA2L,
generates DL sequence at the C-terminus, and leads to binding
of anti-DP (Figure S5). Considering this strict and limited
specificity of anti-DP antibody, the results from the immuno-
chemical analysis indicate that the carboxytermini of native
GluA4 (or GluA2L) receptors do not end with DL, as predicted
by the hypothesized removal of the ‘‘blocking’’ residues by
endogenous enzyme activities.
The results of the present study refute the hypothesis of a
functional cryptic PDZ motif in GluA4 and GluA2L receptors
and have implications for the functional relationships of long-
tailed AMPA receptor subunits, and, evidently, for the interpre-
tation of the observed association of GluA4 with SAP97. Despite
their sequence-level similarities to GluA1 and related roles in
synaptic plasticity, GluA4 and GluA2L receptors do not engage
in direct PDZ interactions. A distinct role for ‘‘non-GluA1’’ long-
tailed subunits is supported by several recent studies which have
highlighted regulatory differences between GluA1 and GluA2L/
GluA4 in signaling pathways involving Ras [37,38] and Jun N-
terminal kinase [39]. The functional implications of coimmuno-
precipitation of native GluA4 AMPA receptors with SAP97, are
not clear, especially as the role of SAP97 even in GluA1-
dependent synaptic plasticity is still poorly understood
[11,12,16,20]. As regards the mechanism of GluA4-SAP97
association, both direct non-PDZ interaction and an indirect
association mediated by other proteins should be considered.
Our finding that wild-type GluA4 or its C-terminal domain do
not show in vitro binding to SAP97 ([13], and this study) would
argue against a direct binary interaction; however, the situation
may be different under physiological conditions. An indirect
assocation would be most easily explained by common interac-
tion partners. Stargazin and related transmembrane AMPA
receptor regulatory proteins (TARP) interact with all AMPA
receptor subunits and carry a type I PDZ motifs in their C-
termini, giving a potential to bind to SAP97 and other Maguks
[40]. It has been reported, however, that, in contrast to PSD-95,
SAP97 does not coimmunoprecipitate with TARP from native
tissue [41]. Another candidate interaction partner for both
GluA4 and SAP97 is 4.1N, a scaffolding protein linked to cell
surface transport and anchorage of GluA1 [42,43] and GluA4
[25] AMPA receptors. In support of this possibility, we have
found that 4.1N and SAP97 coimmunoprecipitate from mouse
brain (Figure S6). This finding may not be unexpected as SAP97
has been shown to bind to 4.1R, another member of 4.1 family
scaffolding proteins, and this binding is mediated by FERM
domain, highly conserved in the 4.1 family [44,45]. Whether
4.1N, GluA4 and SAP97 are all present in the same molecular
complex, thereby explaining the coimmunoprecipitation of
GluA4 with SAP97, is presently unclear.
Conclusion
We conclude that the available evidence does not give any
support for the postulated cleavage of the single carboxy-terminal
blocking residue from GluA4 or GluA2L subunits. If such
processing takes place at all, the processed subunits would
represent a negligible fraction of the total subunit pool, a notion
inconsistent with a significant role in receptor trafficking or
synaptic anchoring. We also found that native GluA4 AMPA
receptors are associated in vivo with SAP97. Whether this novel
interaction is direct, mediated by non-PDZ mechanisms, or
indirect, mediated by other scaffolding proteins like 4.1N, TARPs
and other Maguks [25,37,46] remains to be established.
Materials and Methods
Ethics Statement
Immunization (primary immunization with 300 mg protein; two
boosters, 200 mg each) and collection of sera was performed
according to standard protocols in the Animal Facility of the Viikki
Biocenter, University of Helsinki.
Antibodies and Peptides
Polyclonal rabbit antiserum (Anti-BDL) raised against a glutathi-
one S-transferase (GST) fusion protein of GluA4 C-terminal
residues 836–901, and recognizing wild-type GluA4 and GluA2L,
has been described [35]. An antibody fraction specific for the
processed C-terminus (DP) was isolated from anti-BDL as follows.
Initially, IgGs recognizing the native GluA4 C-terminal domain
were removed from anti-BDL antiserum through extensive
incubation against GST-GluA4 CTD with native C-terminus
(residues 836–902) immobilized on nitrocellulose. After removal of
all immunoreactivity against wild-type GluA4 as monitored by
immunoblotting, the depleted antiserum was incubated with
similarly immobilized GST fusion protein containing GluA4
CTD lacking the carboxy-terminal residue proline-902 (residues
836–901). The bound anti-DP IgGs were eluted in 0.2 M glycine,
pH 2.4, and neutralized by addition of 1 M Tris-HCl, pH 8.0.
Thereafter, the antibody fractions were concentrated and buffer
exchanged into PBS by using 50K Microsep Centrifugal devices
(PALL Life Sciences, Ann Arbour, MI). The purified antibody was
used at 0.35 mg/ml for immunoblotting and for immunofluoresence
labeling at 7 mg/ml.
A generic antiserum against PSD-95 family proteins (anti-
PDZ) was generated by immunizing New Zealand White rabbit
with purified GST fusion protein of rat PSD-95 PDZ domains 1–
3 (residues 213–549; SwissProt P31016). Immunization (primary
immunization with 300 mg protein; two boosters, 200 mg each)
and collection of sera was performed according to standard
protocols in the Animal Facility of the Viikki Biocenter,
University of Helsinki. The antiserum was used at 1:4000 for
immunoblotting.
Fab7, a monoclonal conformation-specific recombinant Fab
antibody recognizing an N-terminal epitope in GluA4 and GluA2,
has been described [36]. All other antibodies have been previously
described, and were used at the following dilutions for immuno-
blotting: anti-GluR-ACTD (GluA1CTD) (serum, 1:2000; [46]); anti-
BDL (GluA2L/GluA4) (serum, 1:1000; purified IgG 0.4 mg/ml;
[35]); anti-DX (GluA4) (serum, 1:2000; [25]); anti-SAP97N (serum,
1:2000; [13]); anti-4.1N (serum, 1:2000; [47]). Commerical
antibodies were used at the dilutions recommended by the
manufacturers: anti-flag M2 (mouse mAb; Sigma), anti-GluR4
(rabbit polyclonal IgG; Sigma), anti-GFP (mouse mAb; Sigma),
anti-myc (rabbit polyclonal IgG; AbCam), anti-Dynamin (mouse
mAb, AbCam). The following secondary antibodies were used;
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anti-mouse-HRP (1:3000; GE Healthcare), anti-rabbit-HRP
(1:8000; GE Healthcare), anti-mouse-Cy3 (1:100; Jackson Immu-
nochemicals) and anti-rabbit-Rhodamine RedX (1:100; Jackson
Immunochemicals).
Synthetic GluA4 carboxy-terminal peptides (13mer, RQSSGLA-
VIASDL; 14mer, RQSSGLAVIASDLP; both with .95% purity)
were purchased from Sigma Genosys, Cambridge, UK.
DNA Constructs
Expression plasmids encoding N-terminally Flag- or GFP-
tagged rat AMPA receptor subunits were constructed in
pcDNA3.1 (Stratagene) as described earlier [25]. C-terminal
mutations were introduced in the expression plasmids by PCR
methodology. The regions encoding the short CTD of GluA4
(GluA4S) and the long CTD of GluA2 (GluA2L) were generated by
PCR, using appropriately designed oligonucleotide primers, and
subcloned into the corresponding pcDNA3.1 expression vectors.
GluA4S cDNA in pBluescript, kindly donated by Dr Andres
Buonanno (NICHHD-NIH, Bethesda, MD), and mouse brain
cDNA served as templates for the PCR reactions. A double-
stranded synthetic oligonucleotide encoding the C-terminal
residues 845–864 of rat dynamin-1 (Swiss-Prot P21575) was
ligated between the BglII and HindIII sites of pEGFP-C1
(Clontech) to generate GFP-Dynamin1-c expression construct.
All new plasmid constructs were verified by restriction mapping
and by complete sequencing of PCR -amplified regions. N-
terminally myc-tagged SAP97, SAP102 and PSD-95 constructs
have been described [46]. Expression constructs for mLin-2 and
mLin10 (in pRK5 plasmid) were generously donated by Dr. Ben
Margolis (University of Michigan, Ann Arbor, MI).
GST Fusion Protein Production and Purification
GST fusion protein constructs were generated in pGEX4-T3
vector and expressed in E.coli BL21 according to manufacturer’s
instructions (GE Healthcare). Briefly, bacterial cultures were
grown at 37uC until OD600 of 0.6, and the protein production
was induced with 1 mM IPTG for 3 hr at 30uC. Bacteria were
pelleted, frozen and resuspended in PBS buffer containing 1 mM
PMSF and sonicated. After centrifugation, the supernatant was
incubated with glutathione-sepharose (GE Healthcare) for two
hours at 4uC. After extensive washing the proteins were eluted in
10 mM glutathione in 50 mM Tris-HCl, pH 8.
Cell Culture, Transfection and Immunocytochemistry
HEK293 and Cos-7 cells were cultured and transfected as
previously described [25]. For co-expression cDNAs were
transfected at a 1:1 ratio. For immunofluoresence staining cells
were grown on poly-D-lysine coated coverslips. The cells were
fixed by 3% paraformaldehyde and blocked against nonspecific
binding by incubation in 3% goat serum containing 0.05% Triton-
X 100. Images were obtained via an Olympus Provis AX70
epifluorescence microscope coupled to a Photometrics SenSys air-
cooled CCD camera.
Immunoprecipitation
Immunoprecipitations were performed essentially as described
previously [13,25]. Briefly, transfected HEK293 cells, or 12-week
mouse brains, or adult rat cerabella were homogenized in 50 mM
Tris-HCl pH 8.0 containing 150 mM NaCl, 5 mM EDTA, 1%
Nonidet P-40, 5 mM NaF, 1 mM Na-pyrophosphate, 1 mM
Na3VO4, 2 mM PMSF and 10 mg/ml aprotinin and leupeptin
(TNE buffer; 1 ml per 50–100 mg tissue). Triton-X 100 was added
to a final concentration of 1% and the homogenate was mixed for
two hours at 4uC, followed by centrifugation at 20000 g for 20 min
at 4uC for HEK cell extracts or 100,000 g for 60 min at 4uC for
brain tissue extracts. The supernatants were pre-cleared by
incubation with GammaBind G-Sepharose (GE Healthcare),
followed by overnight incubation with the appropriate antibody,
antisera or pre-immune sera (2 ml/ml extract) at 4uC. The immune
complexes were harvested by incubation with GammaBind G-
Sepharose (2 h, +4uC). After three 10 minute washes with TNE
buffer and two five minute washes with PBS, the proteins were
eluted in Laemmli’s sample buffer and resolved by SDS-PAGE.
Immunoblotting was performed as described earlier [13,25].
Mass Spectrometry
Rat cerebellar extracts immunoprecipitated with the appropri-
ate antibodies as described above were resolved by SDS-PAGE.
Proteins were visualized by Coomassie Brilliant Blue staining and
bands of interest were cut out and subjected to in-gel digestion
essentially as described by Shevchenko et al. [48]. Briefly, proteins
were reduced with dithiotreitol and alkylated with iodoacetamide
before digestion with sequencing grade modified trypsin (2% wt/
wt; Promega) overnight at 37uC. Peptides were extracted once
with 25 mM ammonium bicarbonate and twice with 5% formic
acid and the extracts were pooled. Prior to MALDI-TOF mass
spectrometric analysis, peptide mixture was desalted and concen-
trated using Millipore m-C18 ZipTips. Peptide mass fingerprint
analysis of the generated peptides was performed with an Ultraflex
MALDI-TOF/TOF mass spectrometer (Bruker-Daltonics, Bre-
men, Germany) in the positive ion reflector mode using a-cyano-4-
hydroxycinnamic acid as the matrix. MALDI-TOF spectra were
externally calibrated with the standard peptide mixture from
Bruker-Daltonics (Bremen, Germany). Database searches were
carried out by Mascot peptide map fingerprint search program
version 2.2 (http://www.matrixscience.com/) using the following
parameters: enzymatic cleavage with trypsin; one potential missed
cleavage; peptide mass tolerances of 650 ppm; modifications due
to carbamidomethylation of Cys (fixed) and oxidation of Met
(variable) were allowed. The initial identifications were then
refined by subjecting all potential AMPA subunits and splice
variants to theoretical tryptic digest with the same parameters
via EXPASY Peptide Mass Tool (http://au.expasy.org/tools/
peptide-mass.html). The resulting predicted peptide masses were
then manually compared to the experimentally generated data.
Supporting Information
Figure S1 Conservation of GluA2L C-terminal sequence in
vertebrate evolution. The indicated GluA2L orthologs represent
diverse vertebrate lineages: mammals (Rattus norvegicus, rat,
P19490), birds (Gallus gallus, chicken, Q90858), bony fishes (Danio
rerio, zebra fish, Q71E58) and amphibians (Xenopus tropicalis,
western clawed frog; the sequence represents a virtual translation of
Genbank EST CX366243). In the alignment, the residues conform-
ing to the class I PDZ motif (-Thr/Ser-X-W; W denoting an amino
acid residue with large aliphatic side chain, X standing for any amino
acid) are highlighted in yellow. Asterisks indicate identical residues,
whereas strong and weak similarities (according to Gonnet Pam250
matrix [40]) are indicated by colons and dots, respectively.
Found at: doi:10.1371/journal.pone.0008715.s001 (0.25 MB TIF)
Figure S2 Characterization of anti-PDZ serum. HEK293 cell
extracts of myc-tagged constructs indicated above and no DNA
(mock) were immunoprecipitated with anti-myc IgG and probed
with antibodies indicated to the left. Anti-PDZ recognizes PSD-95
family Maguk proteins, SAP97, SAP102 and PSD95; but not non-
PSD-95 family PDZ domain-containing proteins, mLin-10 or
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mLin-2. In rat cerebellar tissue extract (CB) the anti-PDZ serum
detects multiple bands, as expected.
Found at: doi:10.1371/journal.pone.0008715.s002 (0.12 MB TIF)
Figure S3 Characterization of an antibody specific for the
exposed PDZ motif in GluA4DP. (A) Immunofluoresence labelling
of PFA-fixed Cos-7 cells transfected with the indicated constructs.
All the subunits are expressed as shown by anti-flag labelling.
However, anti-DP IgG recognises only GluA4DP, not wildtype
GluA4. (B) Specific ablation of signal by pre-incubation of
antibody with peptide. Pre-incubation of anti-DP IgG with molar
excess of 13mer peptide prevented detection of recombinant
GluA4DP, similar treatment with 14mer peptide had no effect (left
hand panels). Conversely, anti-GluR4 was only fully blocked with
the 14mer peptide (right hand panels).
Found at: doi:10.1371/journal.pone.0008715.s003 (0.79 MB TIF)
Figure S4 Anti-DP IgG recognizes rat dynamin1 C-terminus.
(A) Rat cerebellar extract was immunoprecipitated by a panel of
antibodies indicated on top and the samples were probed as
indicated to the left. A 100-kDa dynamin band is present in the
input and in anti-DP immunoprecipitate, but not in anti-BDL or
Fab7 immunoprecipitates (upper panel). Conversely, anti-DP and
dynamin immunoprecipitates do not contain any detectable
GluR4 immunoreactivity (lower panel). (B) HEK293 extracts
containing GFP-dynamin 1[845-864] fusion protein or GFP only
were immunoprecipitated with anti-GFP and immunoblotted with
anti-DP IgG. Anti-DP reacted strongly with the 27-kDa dynamin
fusion but not with GFP (upper panel). Both proteins were
similarly expressed, as shown by the anti-GFP blot (lower panel;
the lower bands correspond to IgG).
Found at: doi:10.1371/journal.pone.0008715.s004 (0.26 MB TIF)
Figure S5 Effect of deletion of the carboxyterminal serine
residue on immunoreactivity and PDZ interactions of GluA2L.(A)
The anti-DP IgG recognizes the exposed PDZ motif in GluA2LDS.
HEK293 cells expressing Flag-tagged GluA2L and GluA2LDS
proteins were immunoblotted with the antibodies indicated below
the panels. The anti-BDL IgG detects both proteins, whereas anti-
DP IgG only detects GluA2LDS. (B) Preincubation of anti-DP IgG
with molar excess of 13mer peptide prevented detection of
recombinant GluA2LDS (right hand panel). (C) GluA2LDS binds
to SAP97 PDZ domains. Extracts of HEK293 cells expressing
Flag-tagged GluA2L and GluA2LDS were incubated with
SAP97[PDZ1-3] GST fusion protein. Input (upper) panel
indicates similar expression of GluA2 proteins. The lower panel
shows only GluA2LDS is pulled down with the PDZ domains. Both
blots were probed with anti-Flag IgG.
Found at: doi:10.1371/journal.pone.0008715.s005 (0.29 MB TIF)
Figure S6 4.1N interacts with SAP97 and AMPA receptors.
Mouse brain extract was subjected to immunoprecipitation with
the antibodies indicated on top and the samples were probed with
anti-4.1N antibody [47]. 4.1N was present in the immunoprecip-
itates produced by antibodies specific for SAP97, PSD-95 Maguks
(anti-PDZ) and GluA2/GluA4 AMPA receptor subunits (Fab7).
Found at: doi:10.1371/journal.pone.0008715.s006 (0.18 MB TIF)
Table S1 Monoisotopic peptide masses observed in the mass
spectrometric analysis of ,100 kDa band in anti-BDL IgG
immunoprecipitate from adult rat crebellum and theoretical mases
of tryptic peptides of rat AMPA receptor subunits.
Found at: doi:10.1371/journal.pone.0008715.s007 (0.04 MB
DOC)
Table S2 Monoisotopic peptide masses observed in the mass
spectrometric analysis of ,100 kDa band in anti-DP IgG
immunoprecipitate from adult rat crebellum and theoretical mases
of tryptic peptides of rat dynamin isoforms. C-terminal peptide is
underlined.
Found at: doi:10.1371/journal.pone.0008715.s008 (0.03 MB
DOC)
Author Contributions
Conceived and designed the experiments: SKC CC KK. Performed the
experiments: SKC CC. Analyzed the data: SKC CC NK KK. Contributed
reagents/materials/analysis tools: NK ERK. Wrote the paper: SKC KK.
References
1. Bredt DS, Nicoll RA (2003) AMPA receptor trafficking at excitatory synapses.
Neuron 40: 361–379.
2. Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA
receptor trafficking. Annu Rev Cell Dev Biol 23: 613–643.
3. Shi S, Hayashi Y, Esteban JA, Malinow R (2001) Subunit-specific rules
governing AMPA receptor trafficking to synapses in hippocampal pyramidal
neurons. Cell 105: 331–343.
4. Passafaro M, Piech V, Sheng M (2001) Subunit-specific temporal and spatial
patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci 4:
917–926.
5. Zhu JJ, Esteban JA, Hayashi Y, Malinow R (2000) Postnatal synaptic
potentiation: Delivery of GluR4-containing AMPA receptors by spontaneous
activity. Nat Neurosci 3: 1098–1106.
6. Kolleker A, Zhu JJ, Schupp BJ, Qin Y, Mack V, et al. (2003) Glutamatergic
plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors.
Neuron 40: 1199–1212.
7. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, et al. (2000) Driving
AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1
and PDZ domain interaction. Science 287: 2262–2267.
8. Mack V, Burnashev N, Kaiser KM, Rozov A, Jensen V, et al. (2001) Conditional
restoration of hippocampal synaptic potentiation in glur-A-deficient mice.
Science 292: 2501–2504.
9. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, et al. (1999)
Importance of AMPA receptors for hippocampal synaptic plasticity but not for
spatial learning. Science 284: 1805–1811.
10. Piccini A, Malinow R (2002) Critical postsynaptic density 95/disc large/zonula
occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at
different subcellular sites. J Neurosci 22: 5387–5392.
11. Kim CH, Takamiya K, Petralia RS, Sattler R, Yu S, et al. (2005) Persistent
hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1.
Nat Neurosci 8: 985–987.
12. Boehm J, Ehrlich I, Hsieh H, Malinow R (2006) Two mutations preventing
PDZ-protein interactions of GluR1 have opposite effects on synaptic plasticity.
Learn Mem 13: 562–565.
13. Cai C, Coleman SK, Niemi K, Keinanen K (2002) Selective binding of synapse-
associated protein 97 to GluR-A alpha-amino-5-hydroxy-3-methyl-4-isoxazole
propionate receptor subunit is determined by a novel sequence motif. J Biol
Chem 277: 31484–31490.
14. Leonard AS, Davare MA, Horne MC, Garner CC, Hell JW (1998) SAP97 is
associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
receptor GluR1 subunit. J Biol Chem 273: 19518–19524.
15. Sans N, Racca C, Petralia RS, Wang YX, McCallum J, et al. (2001) Synapse-
associated protein 97 selectively associates with a subset of AMPA receptors early
in their biosynthetic pathway. J Neurosci 21: 7506–7516.
16. Rumbaugh G, Sia GM, Garner CC, Huganir RL (2003) Synapse-associated
protein-97 isoform-specific regulation of surface AMPA receptors and synaptic
function in cultured neurons. J Neurosci 23: 4567–4576.
17. Stricker NL, Huganir RL (2003) The PDZ domains of mLin-10 regulate its
trans-golgi network targeting and the surface expression of AMPA receptors.
Neuropharmacology 45: 837–848.
18. Hirbec H, Perestenko O, Nishimune A, Meyer G, Nakanishi S, et al. (2002) The
PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor
subtypes. analysis of PDZ binding motifs. J Biol Chem 277: 15221–15224.
19. Uchino S, Wada H, Honda S, Nakamura Y, Ondo Y, et al. (2006) Direct
interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synaptic
molecule Shank3 with GluR1 alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid receptor. J Neurochem 97: 1203–1214.
20. Nakagawa T, Futai K, Lashuel HA, Lo I, Okamoto K, et al. (2004) Quaternary
structure, protein dynamics, and synaptic function of SAP97 controlled by L27
domain interactions. Neuron 44: 453–467.
21. DeGiorgis JA, Galbraith JA, Dosemeci A, Chen X, Reese TS (2006) Distribution
of the scaffolding proteins PSD-95, PSD-93, and SAP97 in isolated PSDs. Brain
Cell Biol 35: 239–250.
Analysis of GluA4 C-Terminus
PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8715
22. Waites CL, Specht CG, Hartel K, Leal-Ortiz S, Genoux D, et al. (2009)
Synaptic SAP97 isoforms regulate AMPA receptor dynamics and access to
presynaptic glutamate. J Neurosci 29: 4332–4345.
23. Valtschanoff JG, Burette A, Davare MA, Leonard AS, Hell JW, et al. (2000)
SAP97 concentrates at the postsynaptic density in cerebral cortex. Eur J Neurosci
12: 3605–3614.
24. Keifer J, Clark TG (2003) Abducens conditioning in in vitro turtle brain stem
without cerebellum requires NMDA receptors and involves upregulation of
GluR4-containing AMPA receptors. Exp Brain Res 151: 405–410.
25. Coleman SK, Cai C, Mottershead DG, Haapalahti JP, Keinanen K (2003)
Surface expression of GluR-D AMPA receptor is dependent on an interaction
between its C-terminal domain and a 4.1 protein. J Neurosci 23: 798–806.
26. Correia SS, Duarte CB, Faro CJ, Pires EV, Carvalho AL (2003) Protein kinase
C gamma associates directly with the GluR4 alpha-amino-3-hydroxy-5-methyl-
4-isoxazole propionate receptor subunit. effect on receptor phosphorylation.
J Biol Chem 278: 6307–6313.
27. Nuriya M, Oh S, Huganir RL (2005) Phosphorylation-dependent interactions of
alpha-actinin-1/IQGAP1 with the AMPA receptor subunit GluR4. J Neurochem
95: 544–552.
28. Kalinina E, Biswas R, Berezniuk I, Hermoso A, Aviles FX, et al. (2007) A novel
subfamily of mouse cytosolic carboxypeptidases. FASEB J 21: 836–850.
29. Hammond JW, Cai D, Verhey KJ (2008) Tubulin modifications and their
cellular functions. Curr Opin Cell Biol 20: 71–76.
30. Musleh W, Bi X, Tocco G, Yaghoubi S, Baudry M (1997) Glycine-induced long-
term potentiation is associated with structural and functional modifications of
alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. Proc
Natl Acad Sci U S A 94: 9451–9456.
31. Bi X, Chen J, Dang S, Wenthold RJ, Tocco G, et al. (1997) Characterization of
calpain-mediated proteolysis of GluR1 subunits of alpha-amino-3-hydroxy-5-
methylisoxazole-4-propionate receptors in rat brain. J Neurochem 68:
1484–1494.
32. Araujo IM, Verdasca MJ, Leal EC, Bahr BA, Ambrosio AF, et al. (2004) Early
calpain-mediated proteolysis following AMPA receptor activation compromises
neuronal survival in cultured hippocampal neurons. J Neurochem 91:
1322–1331.
33. Yuen EY, Liu W, Yan Z (2007) The phosphorylation state of GluR1 subunits
determines the susceptibility of AMPA receptors to calpain cleavage. J Biol
Chem 282: 16434–16440.
34. Meyer EL, Gahring LC, Rogers SW (2002) Nicotine preconditioning
antagonizes activity-dependent caspase proteolysis of a glutamate receptor.
J Biol Chem 277: 10869–10875.
35. Coleman SK, Moykkynen T, Cai C, von Ossowski L, Kuismanen E, et al. (2006)
Isoform-specific early trafficking of AMPA receptor flip and flop variants.
J Neurosci 26: 11220–11229.
36. Jespersen LK, Kuusinen A, Orellana A, Keinanen K, Engberg J (2000) Use of
proteoliposomes to generate phage antibodies against native AMPA receptor.
Eur J Biochem 267: 1382–1389.
37. Qin Y, Zhu Y, Baumgart JP, Stornetta RL, Seidenman K, et al. State-dependent
Ras signaling and AMPA receptor trafficking. Genes Dev 19: 2000–2015.
38. Hu H, Qin Y, Bochorishvili G, Zhu Y, van Aelst L, et al. (2008) Ras signaling
mechanisms underlying impaired GluR1-dependent plasticity associated with
fragile X syndrome. J Neurosci 28: 7847–7862.
39. Thomas GM, Lin D-T, Nuriya M, Huganir RL (2008) Rapid and bi-directional
regulation of AMPA receptor phosphorylation and trafficking by JNK. EMBO J
27: 361–372.
40. Tomita S, Chen L, Kawasaki Y, Petralia RS, Wenthold RJ, et al. (2003)
Functional studies and distribution define a family of transmembrane AMPA
receptor regulatory proteins. J Cell Biol 161: 805–816.
41. Dakoji S, Tomita S, Karimzadegan S, Nicoll RA, Bredt DS (2003) Interaction of
transmembrane AMPA receptor regulatory proteins with multiple membrane
associated guanylate kinases. Neuropharmacology 45: 849–856.
42. Shen L, Liang F, Walensky LD, Huganir RL (2000) Regulation of AMPA
receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal
association. J Neurosci 20: 7932–7940.
43. Lin DT, Makino Y, Sharma K, Hayashi T, Neve R, et al. (2009) Regulation of
AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and
palmitoylation. Nat Neurosci 12: 879–887.
44. Lue RA, Marfatia SM, Branton D, Chishti AH (1994) Cloning and
characterization of hdlg: the human homologue of the Drosophila discs large
tumor suppressor binds to protein 4.1. Proc Natl Acad Sci USA 91: 9818–9822.
45. Hanada T, Takeuchi A, Sondarva G, Chishti AH (2003) Protein 4.1-mediated
membrane targeting of human discs large in epithelial cells. J Biol Chem 278:
34445–34450.
46. Cai C, Li H, Rivera C, Keinanen K (2006) Interaction between SAP97 and
PSD-95, two maguk proteins involved in synaptic trafficking of AMPA receptors.
J Biol Chem 281: 4267–4273.
47. Li H, Khirug S, Cai C, Ludwig A, Blaesse P, et al. (2007) KCC2 interacts with
the dendritic cytoskeleton to promote spine development. Neuron 56:
1019–1033.
48. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric
sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:
850–858.
49. Gonnet GH, Cohen MA, Benner SA (1992) Exhaustive matching of the entire
protein sequence database. Science 256: 1443–1445.
Analysis of GluA4 C-Terminus
PLoS ONE | www.plosone.org 8 January 2010 | Volume 5 | Issue 1 | e8715
